Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr. MartensDOCMF +2.54%55 3-Year Revenue Growth Rate is -7.90% as of Mar. 2026. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 999 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks worse than 73.87% on this metric.
During the past 12 months, Dr. Martens's average Revenue per Share Growth Rate was -3.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -7.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -1.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of Dr. Martens was 30.40% per year. The lowest was -7.90% per year. And the median was 9.45% per year.
Dr. Martens (OTCPK:DOCMF) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Dr. Martens 3-Year Revenue Growth Rate Related Terms
DOCMF vs NKE, DECK, ONON: 3-Year Revenue Growth Rate Comparison
For the Footwear & Accessories subindustry, Dr. Martens's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens 3-Year Revenue Growth Rate vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Dr. Martens's 3-Year Revenue Growth Rate falls into.
Dr. Martens 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of -7.90% mean?
Dr. Martens (DOCMF) has a 3-Year Revenue Growth Rate of -7.90% as of Mar. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Dr. Martens and its competitors. According to the industry distribution chart, Dr. Martens ranks #738 out of 999 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 73.9%.
Is Dr. Martens' 3-Year Revenue Growth Rate too high?
Dr. Martens' current 3-Year Revenue Growth Rate is -7.90%. Based on the distribution chart, Dr. Martens ranks #738 out of 999 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' 3-Year Revenue Growth Rate compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #738 out of 999 companies for 3-Year Revenue Growth Rate. This places Dr. Martens in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Manufacturing - Apparel & Accessories company?
A good 3-Year Revenue Growth Rate depends on the Manufacturing - Apparel & Accessories industry context. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Dr. Martens and its competitors. Dr. Martens's current 3-Year Revenue Growth Rate is -7.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.97, compared to a current price of $1.21 — trading 24.7% above its estimated fair value. The current 3-Year Revenue Growth Rate is -7.90%. Dr. Martens' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current 3-Year Revenue Growth Rate is -7.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of $1.21 is trading 24.7% above its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Modestly Overvalued.
Key valuation signals for DOCMF:
3-Year Revenue Growth Rate: -7.90%
GF Value™: $0.97 vs. price of $1.21 (24.7% above fair value)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score
Get the complete analysis for DOCMF
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
